The AI Workforce PREPARE Act requires the Department of Labor to collect and analyze data on how artificial intelligence affects jobs, including tracking AI adoption by employers and forecasting impacts on specific occupations. It establishes an AI Workforce Research Hub to lead this effort, mandates new survey questions about AI in the workplace, and requires employers to disclose when AI contributes to mass layoffs. The bill creates detailed employment forecasts for occupations most affected by AI, with prediction intervals showing uncertainty ranges, and aims to integrate this data into workforce training programs. These provisions are designed to help workers, employers, and policymakers prepare for AI-driven changes in the labor market.
The FAIR Leave Act (S 3321) repeals a 12-month waiting period requirement under the Family and Medical Leave Act (FMLA) for spouses seeking leave. It directly affects spouses of employees covered by FMLA, removing a previous barrier to immediate eligibility. The key provision eliminates Section 102(f) of the FMLA, which had required spouses to work for 12 months before qualifying for leave. This change allows spouses to access FMLA leave from their first day of employment, without waiting for a year. The bill makes no other changes to FMLA provisions.
The Rx ACCESS Act improves prescription drug access for TRICARE beneficiaries, including military service members, retirees, and their families, by establishing fair reimbursement standards for pharmacies and expanding medication choice. It requires pharmacies to be reimbursed at actual drug costs (or the national average drug cost for certain medications) plus a standard dispensing fee, while banning hidden fees like point-of-sale charges. Starting October 1, 2026, beneficiaries can choose how they receive non-generic medications for ongoing health conditions. The law also mandates annual audits to verify reimbursement fairness and ensure pharmacy networks provide accessible care, especially in rural and underserved areas.
Building Resources and Access for Veterans' Mental Health Engagement Act of 2025 or the BRAVE Act of 2025 This bill addresses mental health services and care provided by the Department of Veterans Affairs (VA), including matters related to personnel, Vet Center administration, care for women veterans, and access to care. The bill authorizes the VA to waive the licensure or certification requirement for individual licensed professional mental health counselor appointees for a reasonable period of time. The bill also extends the Staff Sergeant Parker Gordon Fox Suicide Prevention Grant Program and increases the maximum annual grant amount. The VA must provide Vet Centers with guidance for assessing outreach activities and implement processes to periodically assess the extent to which (1) veterans and eligible members of the Armed Forces experience barriers to obtaining services at Vet Centers, and (2) Vet Center staff may encounter barriers to providing services. Among other requirements, the VA must also survey and host listening sessions with women veterans to gauge the effectiveness of the VA’s suicide prevention, lethal-means safety, and mental health resources and messaging campaigns; initiate efforts to modify the Recovery Engagement and Coordination for Health-Veterans Enhanced Treatment (REACH VET) program to incorporate risk factors weighted for women; annually offer a mental health consultation to veterans who are receiving compensation for a service-connected disability relating to a mental health diagnosis; and implement a pilot program to provide access to mental health residential treatment programs for veterans with a spinal cord injury or disorder.
This bill would remove restrictions on U.S. military exports to the Republic of Cyprus, allowing the Cypriot government to purchase U.S. defense equipment and services. It directly affects Cyprus by enabling access to U.S. defense articles and services, which were previously subject to a policy of denial. The key mechanism eliminates the denial policy for such exports, with exceptions if credible human rights concerns exist, and requires annual congressional certifications to maintain the policy beyond a 5-year period (based on Cyprus's cooperation with U.S. anti-money laundering efforts and denying Russian military vessels port access). The bill does not create new programs but changes existing export restrictions.
This concurrent resolution (SCONRES 24) commemorates the 30th anniversary of the Dayton Peace Accords, signed on December 14, 1995, which ended the Bosnian War. It recognizes the accords' role in halting conflict, ending ethnic cleansing, and establishing peace in Bosnia and Herzegovina, while highlighting Dayton, Ohio's historical role in hosting the negotiations. The resolution reaffirms U.S. support for Bosnia and Herzegovina's sovereignty, EU/NATO partnership, and constitutional reforms, but contains no new laws or direct impacts on any group. As a ceremonial resolution, it does not alter policy or affect any individuals or entities.
HRES 856 is a non-binding resolution expressing the House of Representatives' view that the U.S. Department of Agriculture (USDA) should use its existing contingency funds and interchange authority to fund the Supplemental Nutrition Assistance Program (SNAP) for November 2025. The resolution cites that the USDA holds over $5 billion in contingency funds set aside for emergencies and has legal authority under the Department of Agriculture Organic Act to transfer funds between nutrition programs to maintain SNAP benefits. This would directly support approximately 42 million people relying on SNAP, including 16 million children, 8 million seniors, 4 million people with disabilities, and 1.2 million veterans, preventing disruption during a potential funding gap. The resolution does not create new law but urges the administration to use existing resources to ensure continued food assistance.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
This bill requires the Secretaries of Defense and Veterans Affairs to evaluate existing research on menopause, perimenopause, and mid-life health for women serving in the military or who are veterans. It directs them to identify gaps in knowledge about treatments for symptoms, the impact of military service (including combat exposure and toxins like PFAS), and the availability of care and training for healthcare providers. Within 180 days of enactment, the departments must submit a report and strategic plan to Congress detailing findings and outlining steps to address research gaps and improve care. The law directly affects military women, veterans, and their healthcare providers by aiming to enhance understanding and services for menopause-related health issues.
HR 4549, the Office of Rural Affairs Enhancement Act, amends the Small Business Administration's structure to better serve rural small businesses. It requires the Office's Assistant Administrator to have specific rural business expertise and mandates new outreach activities, including regional webinars and events for rural small business owners. The bill also adds annual reporting requirements for the SBA, detailing the Office's budget, staff, outreach events, and analysis of lending programs targeting rural businesses. These changes directly affect rural small business concerns (defined as those in rural areas per SBA rules) and the SBA's operational approach to their support. The legislation focuses on strengthening the Office's capacity to connect rural businesses with federal resources.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
HR 6335, the "Education Not Endless Scrolling Act," imposes a 50% tax on large digital advertising companies (those with over $2.5 billion in annual U.S. digital ad revenue) starting in 2026. The tax revenue funds three new trust funds: one for local journalism support, one for individual tutoring programs in schools, and one for career and technical education initiatives. These trust funds will distribute one-third of the collected tax revenue to directly support journalism entities, school tutoring programs, and career education programs without requiring new annual appropriations. The bill’s key mechanism is redirecting tax revenue from major digital ad platforms to specific education and journalism programs, effective for taxes paid after December 31, 2025.
